Screener
Champions Oncology CSBR Q3 2025 earnings
Reported September 15, 2025 · After market close
Revenue$14.0MMiss by $47.0K
EPS-$0.03Miss by $0.04
Revenue estimate$14.0M
EPS estimate$0.01
Next report
Sep 14, 2026 (In 2 weeks)Revenue estimate$15.0M
EPS estimate-$0.01
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Champions Oncology report Q3 2025 earnings?
- Champions Oncology (CSBR) reported Q3 2025 earnings on September 15, 2025 after market close.
- What were Champions Oncology's Q3 2025 revenue and EPS?
- Champions Oncology reported revenue of $14.0M and eps of $-0.03 for Q3 2025.
- Did Champions Oncology beat estimates in Q3 2025?
- Revenue missed the consensus estimate of $14.0M by $47.0K. EPS missed the consensus estimate of $0.01 by $0.04.
- How did Champions Oncology's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 0.5% from $14.1M a year earlier.
- Where can I find Champions Oncology's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0000771856-25-000022) and the 10-Q periodic report (0000771856-25-000023) directly on SEC EDGAR. The filing index links above go to sec.gov.
